Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
---|
12/11/2012 | US8329462 Methods and compositions relating to improved lentiviral vectors and their applications |
12/11/2012 | US8329442 Salmonella bacteriophage and antibacterial composition comprising the same |
12/11/2012 | US8329165 Composition for the treatment of ballast water containing bacteriophage as an effective component and biological method with the same for removing bacteria present in ballast water |
12/11/2012 | US8329164 Methods and compositions concerning poxviruses and cancer |
12/11/2012 | CA2481479C Novel flavivirus antigens |
12/06/2012 | WO2012167144A1 Nanocoatings for biological materials |
12/06/2012 | WO2012167139A2 Engineered respiratory syncytial viruses with control of cell-to-cell virus transmission for enhanced safety of live virus vaccines |
12/06/2012 | WO2012165542A1 Mutant replicon derived from genome of hepatitis c virus j6cf strain |
12/06/2012 | WO2012164413A2 Wdr13 as a novel biomarker useful for treating diabetes and cancer |
12/06/2012 | WO2012164130A1 Deficient cell construct in a negative influenza virus modulator for increasing vaccine virus production |
12/06/2012 | WO2012142529A3 Clonal strains of attenuated vaccinia viruses and methods of use thereof |
12/06/2012 | US20120309056 Fed-batch process using concentrated cell culture medium for the efficient production of biologics in eb66 cells |
12/06/2012 | US20120309032 Animal Model Having a Chimeric Human Liver and Suceptible to Human Hepatitis C Virus Infection |
12/06/2012 | US20120308995 Vaccinia virus mutants containing the major genomic deletions of mva |
12/06/2012 | US20120308602 Recombinant RSV Virus Expression Systems And Vaccines |
12/06/2012 | US20120308601 Methods and materials for treating cancer |
12/06/2012 | US20120308594 Hcv clade and prototype sequences thereof |
12/06/2012 | US20120308484 Clonal strains of attenuated vaccinia viruses and methods of use thereof |
12/06/2012 | CA2837279A1 Mutant replicon derived from genome of hepatitis c virus j6cf strain |
12/05/2012 | EP2530161A2 Process for producing poxviruses and poxvirus compositions |
12/05/2012 | EP2530147A2 Influenza hemagglutinin and neuraminidase variants |
12/05/2012 | EP2530086A1 Processes for packaging oligonucleotides into virus-like particles of RNA bacteriophages |
12/05/2012 | EP2529020A1 A scalable manufacturing platform for viral vector purification and viral vectors so purified for use in gene therapy |
12/05/2012 | EP2529010A1 Vaccinia virus mutants containing the major genomic deletions of mva |
12/05/2012 | CN102807992A Method for structuring CAV (Chicken Anemia Virus) infectious molecular clone |
12/05/2012 | CN102807989A Preparation method of recombination live vector vaccines for diseases of canid and/or feline |
12/05/2012 | CN102807972A Hepatitis A virus purification method |
12/05/2012 | CN102807970A Canine distemper virus (CDV) sensitive cell line and establishment method and application thereof |
12/05/2012 | CN102807969A Transgenic insect cell line for high-yield baculovirus, and preparation method and application thereof |
12/05/2012 | CN102807968A Transgenic fat body cell line of high-yield baculovirus and preparation method as well as application thereof |
12/05/2012 | CN102805863A Preparation method of novel bunyavirus purification inactivated vaccine by culturing human diploid cell |
12/05/2012 | CN102206614B Novel method for preparing mixed glue solution for purifying virus plaques and cloning viruses |
12/04/2012 | US8323959 Microorganisms for therapy |
12/04/2012 | US8323658 Infectious bursal disease virus antigenic isolates and vaccines |
12/04/2012 | CA2371714C Streptococcus pneumoniae proteins and vaccines |
11/29/2012 | WO2012162137A1 Hepatitis c virus particles, vaccines, compositions and methods related thereto |
11/29/2012 | WO2012159774A1 Novel listeria bacteriophage p825n and uses thereof |
11/29/2012 | WO2012159562A1 Truncated human papillomavirus type 33 protein l1 |
11/29/2012 | WO2012159522A1 Canine influenza recombinant virus, preparation method therefor and application thereof |
11/29/2012 | US20120301503 Influenza hemagglutinin and neuraminidase variants |
11/29/2012 | US20120301499 Packaging of Immunostimulatory Substances into Virus-Like Particles: Method of Preparation and Use |
11/29/2012 | US20120301462 Compounds |
11/29/2012 | US20120301461 1d05 pcsk9 antagonists |
11/29/2012 | US20120301433 Bacteriophages expressing amyloid peptides and uses thereof |
11/29/2012 | CA2837126A1 Canine influenza recombinant virus, preparation method therefor and application thereof |
11/28/2012 | EP2526966A2 Herpes simplex virus combined subunit vaccines and methods of use thereof |
11/28/2012 | CN102803478A Improved Methods For Purification Of Recombinant Aav Vectors |
11/28/2012 | CN102803477A New clone of newcastle disease virus, its manufacture and its application in the medical treatment of cancer |
11/28/2012 | CN102802666A Swine Influenza Hemagglutinin Variants |
11/28/2012 | CN102796749A Epidemic encephalitis B/dengue chimeric virus with epidemic encephalitis B virus attenuated strain as gene framework and application of epidemic encephalitis B/dengue chimeric virus |
11/28/2012 | CN102796710A Non-pathogenic recombinant attenuated rabies virus strain and construction method and application thereof |
11/28/2012 | CN102796709A Liver cancer-specific gene-virus and application thereof |
11/28/2012 | CN102796708A Method for proliferating influenza A viruses |
11/28/2012 | CN102796183A Insecticidal protein, and coding gene and purposes thereof |
11/28/2012 | CN102796182A Insecticidal protein, as well as coding gene and application thereof |
11/28/2012 | CN102793917A Porcine encephalitis B vaccine and preparation method thereof |
11/28/2012 | CN101253261B Diagnostic test kits |
11/27/2012 | US8318480 Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor |
11/27/2012 | US8318425 Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein |
11/27/2012 | CA2461579C Porcine adenovirus e1 region |
11/27/2012 | CA2413151C Host cells containing multiple integrating vectors |
11/22/2012 | WO2012156933A1 Combination of oncolytic adenoviruses with histone deacetylase inhibitors |
11/22/2012 | WO2012155262A1 Virus-like particles and process for preparing same |
11/22/2012 | WO2012155261A1 Papaya mosaic virus compositions and uses thereof for stimulation of the innate immune response |
11/22/2012 | WO2012129873A3 Method for preparing antitumor biological product |
11/22/2012 | WO2012115474A3 Novel varicella-zoster virus strains, and chicken pox and herpes zoster virus vaccine using same |
11/22/2012 | US20120295813 Plasmids and methods for peptide display and affinity-selection on virus-like particles of rna bacteriophages |
11/22/2012 | US20120294892 Avirulent Salmonella Gallinarum Variants and Pharmaceutical Composition Using the Same |
11/22/2012 | US20120294890 Recombinant Parainfluenza Virus Expression Systems And Vaccines |
11/22/2012 | US20120294889 Chimeric Flavivirus Vaccines |
11/22/2012 | CA2835972A1 Virus-like particles and process for preparing same |
11/22/2012 | CA2835967A1 Papaya mosaic virus compositions and uses thereof for stimulation of the innate immune response |
11/21/2012 | EP2523681A1 Methods of producing adenovirus vectors and viral preparations generated thereby |
11/21/2012 | CN102791852A Method for the purification of adenovirus particles |
11/21/2012 | CN102791288A Recombinant attenuated parvovirus |
11/21/2012 | CN102787119A Products and methods for treatment and/or prevention of virus infections |
11/21/2012 | CN102787102A Porcine alpha interferon mature-protein recombinant adenovirus, construction method and application thereof |
11/21/2012 | CN102787101A 24-dehydrocholesterol reductase coded recombinant adenoviruses specifically expressed in tissue |
11/21/2012 | CN102787100A High-prolificacy porcine circovirus type-2 strain and application thereof |
11/21/2012 | CN102787099A Chick embryo culture method for White spot syndrome virus |
11/21/2012 | CN102786585A Insecticidal protein, coding gene of insecticidal protein and purpose of insecticidal protein |
11/21/2012 | CN102786584A Insecticidal protein, coding gene of insecticidal protein and purpose of insecticidal protein |
11/21/2012 | CN102784390A Method for preparing thermal-stability vaccine |
11/21/2012 | CN102268412B Hepatitis C virus (HCV) nonstructural protein/GB virus B (GBV-B) hybrid virus |
11/21/2012 | CN102174477B Hepatitis A virus strain SH and diploid cell adaptation method thereof |
11/21/2012 | CN102174476B Inactivated vaccine for preventing duck virus hepatitis and preparation method thereof |
11/21/2012 | CN101914139B Human papilloma virus (HPV) capsid protein L1 polypeptide and preparation and application thereof |
11/21/2012 | CN101580849B Dna-transfection system for generation of infectious influenza virus |
11/20/2012 | CA2762042C Chimeric influenza virus-like particles comprising hemagglutinin |
11/20/2012 | CA2343653C Recombinant newcastle disease virus rna expression systems and vaccines |
11/15/2012 | WO2012154994A2 A novel adenovirus isolated from titi monkeys |
11/15/2012 | WO2012069190A3 Depletion of host cell components from live virus vaccines |
11/15/2012 | US20120288916 Immortalized avian cell lines for virus production |
11/15/2012 | US20120288522 Novel Pneumovirus Compositions and Methods For Using the Same |
11/15/2012 | US20120288521 Multi plasmid system for the production of influenza virus |
11/15/2012 | US20120288520 Recombinant Flavivirus Vaccines |
11/14/2012 | EP2522719A1 Influenza hemagglutinin and neuraminidase variants |
11/14/2012 | CN102776198A Method for expressing recombinant human bone morphogenetic protein in insect cell |
11/14/2012 | CN102776179A Wheat dwarf gene tandem repeat fragment and application thereof |
11/14/2012 | CN102776156A Gene VIb subtype Rubulavirus Newcastle disease virus attenuated strain VIbI4 and construction method thereof |